신경성기립저혈압의 치료 = Treatment of Neurogenic Orthostatic Hypotension

다국어 초록 (Multilingual Abstract)

Orthostatic hypotension (OH) is a common feature of sympathetic autonomic dysfunction and can lead to lightheadedness, weakness, dizziness, and syncope. It is defined as decrease in systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within 3 minutes of standing. OH is associated with an increased incidence of cerebrovascular disease, myocardial infarction, and mortality. Non-pharmacological treatments may alleviate OH-re-lated symptoms; however, are not sufficient when used alone. Pharmacological treatment is essential in managing OH. In this review, we aimed to discuss non-pharmacological and pharmacological treatment options for OH.

참고문헌 (Reference)

1 Hale GM, "The treatment of primary orthostatic hypotension" 51 : 417-428, 2017

2 Gibbons CH, "The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension" 264 : 1567-1582, 2017

3 Benarroch EE., "The clinical approach to autonomic failure in neurological disorders" 10 : 396-407, 2014

4 Benditt DG, "Syncope: therapeutic approaches" 53 : 1741-1751, 2009

5 El-Sayed H, "Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope" 75 : 134-140, 1996

6 Singer W, "Pyridostigmine treatment trial in neurogenic orthostatic hypotension" 63 : 513-518, 2006

7 Sandroni P, "Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]: a follow-up survey study" 15 : 51-53, 2005

8 Schreglmann SR, "Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease: a randomized controlled trial" 24 : 545-551, 2017

9 Low PA, "Prospective evaluation of clinical characteristics of orthostatic hypotension" 70 : 617-622, 1995

10 Hiitola P, "Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged 75 years or older" 23 : 33-39, 2009

11 Wieling W, "Physical countermeasures to increase orthostatic tolerance" 277 : 69-82, 2015

12 Zachariah PK, "Pharmacodynamics of midodrine, an antihypotensive agent" 39 : 586-591, 1986

13 Pittner H, "Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059" 26 : 2145-2154, 1976

14 Ooi WL, "Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population" 277 : 1299-1304, 1997

15 Smit AA, "Pathophysiological basis of orthostatic hypotension in autonomic failure" 519 (519): 1-10, 1999

16 Jones PK, "Orthostatic hypotension: managing a difficult problem" 13 : 1263-1276, 2015

17 Jodaitis L, "Orthostatic hypotension and associated conditions in geriatric inpatients" 70 : 251-258, 2015

18 Veronese N, "Orthostatic changes in blood pressure and mortality in the elderly: The Pro.V.A Study" 28 : 1248-1256, 2015

19 Schoffer KL, "Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease" 22 : 1543-1549, 2007

20 Jankovic J, "Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine" 95 : 38-48, 1993

21 Parsaik AK, "Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials" 28 : 1496-1503, 2013

22 Izcovich A, "Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review" 83 : 1170-1177, 2014

23 Low PA, "Management of neurogenic orthostatic hypotension: an update" 7 : 451-458, 2008

24 Isaacson SH., "Managed care approach to the treatment of neurogenic orthostatic hypotension" 21 : s258-s268, 2015

25 Podoleanu C, "Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons:a randomized single-blind controlled study" 48 : 1425-1432, 2006

26 Krediet CT, "Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study" 291 : H1768-H1772, 2006

27 Wieling W, "Initial orthostatic hypotension: review of a forgotten condition" 112 : 157-165, 2007

28 Bellard E, "Increased hydration alone does not improve orthostatic tolerance in patients with neurocardiogenic syncope" 17 : 99-105, 2007

29 Hussain RM, "Fludrocortisone in the treatment of hypotensive disorders in the elderly" 76 : 507-509, 1996

30 Low PA, "Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study" Midodrine Study Group 277 : 1046-1051, 1997

31 Denq JC, "Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension" 7 : 321-326, 1997

32 Strassheim V, "Droxidopa for orthostatic hypotension: a systematic review and meta-analysis" 34 : 1933-1941, 2016

33 "Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy:The Consensus Committee of the American Autonomic Society and the American Academy of Neurology" 46 : 1470-, 1996

34 Shibao C, "Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure" 56 : 847-851, 2010

35 Ricci F, "Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies" 36 : 1609-1617, 2015

36 Goldstein DS, "Association between supine hypertension and orthostatic hypotension in autonomic failure" 42 : 136-142, 2003

37 Wieling W, "Are small observational studies sufficient evidence for a recommendation of head-up sleeping in all patients with debilitating orthostatic hypotension? MacLean and Allen revisited after 70 years" 19 : 8-12, 2009

38 Arnold AC, "Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure" 61 : 701-706, 2013

39 Singer W, "Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension" 74 : 1294-1298, 2003

40 Jordan J, "A potent pressor response elicited by drinking water" 353 : 723-, 1999

41 Wright RA, "A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension" 51 : 120-124, 1998

42 Campbell IW, "9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy" 24 : 381-384, 1975